• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

确证性适应性人群富集试验中的设计问题

Designing Issues in Confirmatory Adaptive Population Enrichment Trials.

作者信息

Wassmer Gernot, Dragalin Vlad

机构信息

a Aptiv Solutions , Reston , Virginia , USA.

出版信息

J Biopharm Stat. 2015;25(4):651-69. doi: 10.1080/10543406.2014.920869.

DOI:10.1080/10543406.2014.920869
PMID:24905739
Abstract

Adaptive population enrichment designs enable the data-driven selection of one or more pre-specified subpopulations in an interim analysis, and the confirmatory proof of efficacy in the selected subset at the end of the trial. Sample size reassessment and other adaptive design changes can be performed as well. Strong control of the experimentwise Type I error rate is guaranteed by use of the combination testing principle together with the closed testing argument. In this paper the general methodology and designing issues when planning such a design are reviewed. It is shown how to derive overall confidence intervals and p-values. Criteria for assessing the operating characteristics of these designs are given, and the application is illustrated by examples.

摘要

适应性群体富集设计能够在期中分析中通过数据驱动选择一个或多个预先指定的亚组,并在试验结束时对所选亚组进行疗效的确证性证明。也可以进行样本量重新评估和其他适应性设计变更。通过使用联合检验原则和封闭检验论证,能够确保对实验性I型错误率进行严格控制。本文回顾了规划此类设计时的一般方法和设计问题。展示了如何推导总体置信区间和p值。给出了评估这些设计操作特性的标准,并通过实例进行了说明。

相似文献

1
Designing Issues in Confirmatory Adaptive Population Enrichment Trials.确证性适应性人群富集试验中的设计问题
J Biopharm Stat. 2015;25(4):651-69. doi: 10.1080/10543406.2014.920869.
2
On sample size determination in multi-armed confirmatory adaptive designs.多臂验证性适应性设计中的样本量确定
J Biopharm Stat. 2011 Jul;21(4):802-17. doi: 10.1080/10543406.2011.551336.
3
Data-driven analysis strategies for proportion studies in adaptive group sequential test designs.适应性成组序贯试验设计中比例研究的数据驱动分析策略。
J Biopharm Stat. 2003 Nov;13(4):585-603. doi: 10.1081/BIP-120024196.
4
Statistical considerations for testing multiple endpoints in group sequential or adaptive clinical trials.成组序贯或适应性临床试验中多个终点检验的统计学考量
J Biopharm Stat. 2007;17(6):1201-10. doi: 10.1080/10543400701645405.
5
Nested combination tests with a time-to-event endpoint using a short-term endpoint for design adaptations.使用短期终点进行设计调整的具有事件发生时间终点的嵌套组合试验。
Pharm Stat. 2019 May;18(3):329-350. doi: 10.1002/pst.1926. Epub 2019 Jan 16.
6
Repeated confidence intervals for adaptive group sequential trials.适应性成组序贯试验的重复置信区间
Stat Med. 2007 Dec 30;26(30):5422-33. doi: 10.1002/sim.3062.
7
On efficient two-stage adaptive designs for clinical trials with sample size adjustment.关于具有样本量调整的临床试验的高效两阶段自适应设计。
J Biopharm Stat. 2012;22(4):617-40. doi: 10.1080/10543406.2012.678226.
8
The advantages and disadvantages of adaptive designs for clinical trials.临床试验适应性设计的优缺点。
Drug Discov Today. 2004 Apr 15;9(8):351-7. doi: 10.1016/S1359-6446(04)03023-5.
9
Optimizing trial design in pharmacogenetics research: comparing a fixed parallel group, group sequential, and adaptive selection design on sample size requirements.优化药物遗传学研究中的试验设计:比较固定平行组、序贯组和适应性选择设计对样本量的要求。
Pharm Stat. 2013 Nov-Dec;12(6):366-74. doi: 10.1002/pst.1599. Epub 2013 Sep 23.
10
A simple and flexible graphical approach for adaptive group-sequential clinical trials.一种用于适应性成组序贯临床试验的简单灵活的图形方法。
J Biopharm Stat. 2016;26(2):202-16. doi: 10.1080/10543406.2014.972509. Epub 2014 Nov 5.

引用本文的文献

1
Confidence Intervals for Adaptive Trial Designs I: A Methodological Review.适应性试验设计的置信区间I:方法学综述
Stat Med. 2025 Aug;44(18-19):e70174. doi: 10.1002/sim.70174.
2
Toward Precision in Critical Care Research: Methods for Observational and Interventional Studies.迈向重症监护研究的精准化:观察性和干预性研究方法。
Crit Care Med. 2024 Sep 1;52(9):1439-1450. doi: 10.1097/CCM.0000000000006371. Epub 2024 Aug 15.
3
Designing and analyzing clinical trials for personalized medicine via Bayesian models.基于贝叶斯模型设计和分析个性化医学临床试验。
Pharm Stat. 2021 May;20(3):573-596. doi: 10.1002/pst.2095. Epub 2021 Jan 19.
4
Clinical trial design in phase 2 and 3 trials for pulmonary hypertension.肺动脉高压2期和3期试验的临床试验设计。
Pulm Circ. 2020 Jul 20;10(4):2045894020941491. doi: 10.1177/2045894020941491. eCollection 2020 Oct-Dec.
5
Multi-stage adaptive enrichment trial design with subgroup estimation.多阶段自适应富集试验设计与亚组估计。
J Biopharm Stat. 2020 Nov 1;30(6):1038-1049. doi: 10.1080/10543406.2020.1832109. Epub 2020 Oct 18.
6
Point and interval estimation in two-stage adaptive designs with time to event data and biomarker-driven subpopulation selection.具有事件发生时间数据和生物标志物驱动的亚组选择的两阶段自适应设计中的点估计和区间估计。
Stat Med. 2020 Aug 30;39(19):2568-2586. doi: 10.1002/sim.8557. Epub 2020 May 3.
7
Adaptive seamless clinical trials using early outcomes for treatment or subgroup selection: Methods, simulation model and their implementation in R.自适应无缝临床试验,使用早期结果进行治疗或亚组选择:方法、模拟模型及其在 R 中的实现。
Biom J. 2020 Sep;62(5):1264-1283. doi: 10.1002/bimj.201900020. Epub 2020 Mar 2.
8
Adaptive designs in clinical trials: from scientific advice to marketing authorisation to the European Medicine Agency.临床试验中的适应性设计:从向欧洲药品管理局寻求科学建议到获得上市许可
Trials. 2018 Nov 20;19(1):642. doi: 10.1186/s13063-018-3012-x.
9
Methods for identification and confirmation of targeted subgroups in clinical trials: A systematic review.临床试验中靶向亚组的识别与确认方法:一项系统评价
J Biopharm Stat. 2016;26(1):99-119. doi: 10.1080/10543406.2015.1092034.
10
Optimal decision rules for biomarker-based subgroup selection for a targeted therapy in oncology.肿瘤靶向治疗中基于生物标志物的亚组选择的最优决策规则。
Int J Mol Sci. 2015 May 7;16(5):10354-75. doi: 10.3390/ijms160510354.